TriSalus Life Sciences Inc. said it received FDA clearance for Trinav® Advance, strengthening its comprehensive pressure-enabled drug delivery (PEDD™) portfolio for liver embolization.
The company said it intends to initiate a limited market release of the Trinav Advance device over the coming weeks.
TLSI•
